Skip to content

MRI Perfusion in Adnexal Masses

Added Value of MRI Perfusion in Evaluation of Complex Adnexal Masses

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02694406
Acronym
MRI-CAM
Enrollment
40
Registered
2016-02-29
Start date
2015-07-31
Completion date
2017-12-01
Last updated
2018-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complex Adnexal Masses

Keywords

Diagnosis

Brief summary

As ovarian cancer is characterized by an anarchic neovascularization resulting in a wide number of immature microvessels. These vessels are characterized by a lack of coverage by pericytes and the higher expression of one of the receptors of Vascular Endothelial Growth Factor on both endothelial and epithelial cells of ovarian cystadenocarcinomas. These physio pathogenic characteristics have been demonstrated to be in line with variations of MR perfusion parameters. Unlike many lesions that occur in other parts of the body, biopsy should not be performed in adnexal masses that demonstrate no evidence of peritoneal disease because it may cause spillage of cystic contents, potentially leading to iatrogenic up-staging of what may have been a malignant tumor that was limited.

Interventions

DEVICEMRI perfusion

contrast-enhanced MR imaging including perfusion weighted imaging (PWI)

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* complex adnexal mass * patient fit for surgery

Exclusion criteria

* any general contraindication to MRI * severely ill patients * those with claustrophobia.

Design outcomes

Primary

MeasureTime frame
detect the number of malignant adnexal masses2 weeks

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026